SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Wanted: Long-Term "Strong Buy" Recommendations

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Philip H. Lee who wrote ()11/21/1996 3:17:00 PM
From: Tony J Brice   of 54
 
CYTC is probably the kind of company you're looking for. Although a lot of day-traders are making money on this stock right now, it is positioned extremely well for growth. There is a CYTC thread under the SI Biotech section if you want to follow it but here is a summary:

CYTC has developed a method to replace the traditional pap smear. The FDA has approved CYTC's promotion of the new product as SIGNIFICANTLY better than the traditional method. The stock jumped from 12 to over 20 on this FDA approval (couple of weeks ago). It leveled out at around 19.

This week, CYTC's method was approved for payment by the first of what should be several large healthcare insurers, critical in the success of any such product. The stock has risen to over 25 in the last two days on this news.

Although there is some profit-taking along the way with any stock moving this up this quickly, I think smart investors are staying with it. They realize that labs and gyn's won't have much choice but to move to this product given 1) the FDA ruling on its significance and 2) the willingness of insurers to pay for it.

Good Luck!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext